• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

U-97018对清醒正常血压大鼠脑室内注射血管紧张素II所致升压反应的影响。

Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.

作者信息

Morita O, Kushida H, Kunihara M

机构信息

Tsukuba Research Laboratory, Upjohn Pharmaceuticals, Japan.

出版信息

J Cardiovasc Pharmacol. 1995 Jun;25(6):880-7. doi: 10.1097/00005344-199506000-00005.

DOI:10.1097/00005344-199506000-00005
PMID:7564332
Abstract

We examined the effects of U-97018, an AT1 receptor antagonist, on the pressor response to intracerebroventricularly (i.c.v.) administered angiotensin II (AII) in conscious normotensive rats in comparison to losartan, EXP 3174, EXP 655, and saralasin. In an i.c.v. study, U-97018, losartan, and EXP 3174 reduced the pressor response. EXP 655, an AT2 selective antagonist, also inhibited the pressor response to i.c.v. AII. U-97018 combined with EXP 655 did not fully eliminate the pressor response to i.c.v. AII. Moreover, saralasin, a nonselective peptide AII antagonist, also failed to abolish the pressor response to i.c.v. AII. Therefore, both AT1- and AT2-receptors probably are functional in inhibiting the pressor response to i.c.v. AII and that a part of the i.c.v. AII-induced pressor response occurs through non-AT1- and non-AT2-receptors. In an intravenous (i.v.) study, U-97018, losartan, and EXP 3174 reduced the pressor response to i.c.v. AII. At 10 mg/kg orally (p.o.), which is an antihypertensive dose in spontaneously hypertensive rats (SHR), neither U-97018 nor losartan reduced the pressor response to i.c.v. AII even at 180 min after administration. This result indicates that neither U-97018 nor losartan, at the oral antihypertensive dose, reaches the brain in sufficient amount to affect the pressor response to i.c.v. AII.

摘要

我们研究了AT1受体拮抗剂U-97018对清醒正常血压大鼠脑室内(i.c.v.)注射血管紧张素II(AII)所致升压反应的影响,并与氯沙坦、EXP 3174、EXP 655和沙拉新进行了比较。在一项i.c.v.研究中,U-97018、氯沙坦和EXP 3174降低了升压反应。AT2选择性拮抗剂EXP 655也抑制了对i.c.v. AII的升压反应。U-97018与EXP 655联合使用并未完全消除对i.c.v. AII的升压反应。此外,非选择性肽类AII拮抗剂沙拉新也未能消除对i.c.v. AII的升压反应。因此,AT1和AT2受体可能都在抑制对i.c.v. AII的升压反应中发挥作用,且部分i.c.v. AII诱导的升压反应是通过非AT1和非AT2受体发生的。在一项静脉内(i.v.)研究中,U-97018、氯沙坦和EXP 3174降低了对i.c.v. AII的升压反应。在10mg/kg口服(p.o.)剂量下,这是自发性高血压大鼠(SHR)的抗高血压剂量,即使在给药后180分钟,U-97018和氯沙坦也未降低对i.c.v. AII的升压反应。该结果表明,在口服抗高血压剂量下,U-97018和氯沙坦均未足量到达脑内以影响对i.c.v. AII的升压反应。

相似文献

1
Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.U-97018对清醒正常血压大鼠脑室内注射血管紧张素II所致升压反应的影响。
J Cardiovasc Pharmacol. 1995 Jun;25(6):880-7. doi: 10.1097/00005344-199506000-00005.
2
Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.在自发性高血压大鼠中,急性或慢性中枢给予AT1受体拮抗剂后缺乏中枢介导的降压作用。
Br J Pharmacol. 1995 Dec;116(8):3181-90. doi: 10.1111/j.1476-5381.1995.tb15122.x.
3
Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.脑AT1和AT2受体在清醒年轻自发性高血压大鼠中枢血管紧张素II升压反应中的功能作用。
Brain Res Dev Brain Res. 1993 Feb 19;71(2):193-9. doi: 10.1016/0165-3806(93)90171-6.
4
Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats.
Brain Res. 1994 Jun 13;648(1):46-52. doi: 10.1016/0006-8993(94)91903-8.
5
Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.在给予AT1受体拮抗剂EXP 3174后,用AT2受体拮抗剂抑制清醒大鼠体内血管紧张素II的血流动力学效应。
Br J Pharmacol. 1992 Nov;107(3):873-80. doi: 10.1111/j.1476-5381.1992.tb14540.x.
6
Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.脑内AT1和AT2受体阻断对清醒自发性高血压大鼠中枢血管紧张素II升压反应的影响。
Neuropharmacology. 1993 Jun;32(6):581-9. doi: 10.1016/0028-3908(93)90054-7.
7
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.新型高效选择性非肽类血管紧张素II受体拮抗剂L-158,809的体内药理学
J Pharmacol Exp Ther. 1992 Jul;262(1):139-44.
8
The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.血管紧张素、AT1和AT2受体在对中枢血管紧张素的升压、饮水及抗利尿反应中的作用
Brain Res. 1992 Jul 24;586(2):289-94. doi: 10.1016/0006-8993(92)91638-u.
9
Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.氯沙坦对血管紧张素 II 高血压的阻断作用与对血管紧张素 II 快速升压作用的阻断作用的时间进程。
J Pharmacol Exp Ther. 1994 Nov;271(2):804-10.
10
Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.血管紧张素II 1型受体拮抗剂ZD 7155与氯沙坦对大鼠心血管作用的比较
J Pharm Pharmacol. 1996 Aug;48(8):829-33. doi: 10.1111/j.2042-7158.1996.tb03983.x.